SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
85.20    1.20 (1.43%)
Bid:
85.20
Ask:
85.90
Spread: 0.70 (0.822%)
Market Cap: £238.73m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Statement re Launch of Share Buyback Programme

29 Mar 2023 07:05

RNS Number : 5439U
Essentra plc
29 March 2023
 

ESSENTRA PLC

LAUNCH OF SHARE BUYBACK PROGRAMME

On 2 February 2023, Essentra plc ("Essentra", or the "Company") announced its intention to return £150m of capital to shareholders through a combination of a special dividend of £90 million and a share buyback programme of approximately £60 million using the proceeds from the disposal of its Packaging and Filters businesses.

Today, Essentra announces that it intends to commence a share buyback programme, subject to market conditions, to purchase ordinary shares of 25 pence each in the Company ("Ordinary Shares") for up to a maximum aggregate consideration of £60 million from the date of this announcement (the "Buyback Programme"). The Buyback Programme is expected to complete by no later than 31 December 2023.

The Company has entered into an agreement with Peel Hunt LLP ("Peel Hunt") to conduct the Buyback Programme, acting as "riskless" or "matched" principal in accordance with certain contractually agreed parameters. Under this agreement, the Company has instructed Peel Hunt to purchase Ordinary Shares up to a maximum aggregate consideration of £60 million pursuant to the Buyback Programme. The agreement provides Peel Hunt with authority to carry out market purchases under the Buyback Programme with discretion and independently of the Company within the agreed parameters, in order that purchases can continue during closed periods and/or if and when the Company comes into possession of inside information.

The purpose of the Buyback Programme is to reduce the share capital of the Company and return capital to shareholders. The Company intends to cancel the majority of the Ordinary Shares purchased under the Buyback Programme and retain a portion which will be issued from time to time pursuant to the Company's share option schemes.

The directors of the Company consider the Buyback Programme to be in the best interests of the Company and its shareholders, and is expected to enhance earnings per share. Following completion of the Buyback Programme, the Board expects the Group's net financial leverage to remain less than 1.5x, in line with previous guidance.

Any purchase of Ordinary Shares under the Buyback Programme will be carried out on the London Stock Exchange and/or other trading venues.

The Buyback Programme will be conducted in accordance with the general authority to repurchase Ordinary Shares, previously granted by the Company's shareholders at the 2022 Annual General Meeting (the "2022 Authority") and to be sought at the 2023 Annual General Meeting (the "2023 Authority"). The details of the 2022 Authority can be found on the Company's website at https://www.essentraplc.com/en/investors/shareholder-services/agm. The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2022 Authority is 15,084,313. Upon expiry of the 2022 Authority, the maximum number of shares that the Company shall be authorised to purchase will be such number of Ordinary Shares as stated in the 2023 Authority.

The Buyback Programme will be conducted in accordance with Chapter 12 of the Financial Conduct Authority's Listing Rules and the Market Abuse Regulation (EU) No 596/2014 (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019).

The Company will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares under the Buyback Programme by no later than 7.30 a.m. on the business day following the calendar day on which the purchase occurred.

The person responsible for making this announcement on behalf of the Company is Emma Reid, Company Secretary.

 

 

Enquiries

Essentra plc

Emma Reid, Company Secretary

Jack Clarke, Chief Financial Officer

Claire Goodman, Investor Relations Manager

 

Teneo

Olivia Peters

Lisa Jarrett-Kerr

 

Tel: +44 (0)1908 359100

Tel: +44 (0)20 7353 4200

 

 

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes over 3,000 employees, 13 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.74,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRPPUCWWUPWPGR
Date   Source Headline
23rd Oct 201910:35 amRNSHolding(s) in Company
1st Oct 20198:21 amRNSTotal Voting Rights
9th Sep 20197:00 amRNSAcquisition of Nekicesa Packaging S.L.
3rd Sep 20193:45 pmRNSTotal Voting Rights
15th Aug 20198:28 amRNSDirector/PDMR Shareholding
15th Aug 20198:26 amRNSDirector/PDMR Shareholding
14th Aug 201911:08 amRNSDirector/PDMR Shareholding
5th Aug 20197:35 amRNSTotal Voting Rights
2nd Aug 20197:00 amRNSResults for the Half Year Ended 30 June 2019
19th Jul 201910:56 amRNSInvitation to Half Year 2019 Results Presentation
1st Jul 20199:45 amRNSTotal Voting Rights
1st Jul 20197:00 amRNSCompletion of Divestment of Speciality Tapes
27th Jun 20197:00 amRNSAcquisition of Innovative Components
20th Jun 20197:00 amRNSDivestment of Speciality Tapes business
11th Jun 20197:00 amRNSDivestment of Extrusion business
6th Jun 201911:54 amRNSDirector/PDMR Shareholding
3rd Jun 201912:22 pmRNSTotal Voting Rights
3rd Jun 201912:21 pmRNSDirector Declaration
24th May 20197:02 amRNS2019 AGM Results
23rd May 20197:00 amRNSAnnual General Meeting - Trading Update
8th May 20192:12 pmRNSDirector/PDMR Shareholding
7th May 201910:53 amRNSDirector/PDMR Shareholding
1st May 20194:20 pmRNSTotal Voting Rights
12th Apr 20191:40 pmRNSDirector/PDMR Shareholding
12th Apr 201912:20 pmRNSDirector/PDMR Shareholding
8th Apr 20199:54 amRNS2019 Annual General Meeting and Trading Update
3rd Apr 20198:25 amRNSAnnual Report 2018 & 2019 AGM Notice
2nd Apr 20199:45 amRNSDirector/PDMR Shareholding
2nd Apr 20199:44 amRNSDirector/PDMR Shareholding
2nd Apr 20199:43 amRNSDirector/PDMR Shareholding
2nd Apr 20199:42 amRNSDirector/PDMR Shareholding
2nd Apr 20199:42 amRNSDirector/PDMR Shareholding
2nd Apr 20199:41 amRNSDirector/PDMR Shareholding
2nd Apr 20199:35 amRNSDirector/PDMR Shareholding
2nd Apr 20199:33 amRNSDirector/PDMR Shareholding
1st Apr 20194:05 pmRNSTotal Voting Rights
19th Mar 20197:00 amRNSAcquisition of Minority Stake in Filters Division
1st Mar 201910:10 amRNSTotal Voting Rights
1st Mar 20197:05 amRNSAppointment of Non-Executive Director
1st Mar 20197:00 amRNSFinal Results
19th Feb 201911:33 amRNSInvitation to FY 2018 Results Presentation
1st Feb 201910:04 amRNSTotal Voting Rights
14th Jan 20192:44 pmRNSDisposal of Pipe Protection Technologies Business
2nd Jan 20191:49 pmRNSTotal Voting Rights
3rd Dec 201810:27 amRNSTotal Voting Rights
16th Nov 201812:45 pmRNSDirectorate Change
15th Nov 20189:15 amRNSDirectorate Change
2nd Nov 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 201812:35 pmRNSDirector/PDMR Shareholding
24th Oct 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.